While CryoPort Inc has overperformed by 2.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CYRX fell by -31.35%, with highs and lows ranging from $24.17 to $9.00, whereas the simple moving average jumped by 11.37% in the last 200 days.
On May 03, 2024, B. Riley Securities Downgraded CryoPort Inc (NASDAQ: CYRX) to Neutral. Needham also reiterated CYRX shares as ‘Buy’, quoting a target price of $18 on the company’s shares in a report dated March 13, 2024. Morgan Stanley Initiated an Equal-Weight rating on August 17, 2023, and assigned a price target of $16. Stephens August 10, 2023d its ‘Overweight’ rating to ‘Equal-Weight’ for CYRX, as published in its report on August 10, 2023. UBS’s report from July 18, 2023 suggests a price prediction of $17 for CYRX shares, giving the stock a ‘Neutral’ rating. KeyBanc Capital Markets also rated the stock as ‘Sector Weight’.
Analysis of CryoPort Inc (CYRX)
Further, the quarter-over-quarter decrease in sales is -5.13%, showing a negative trend in the upcoming months.
One of the most important indicators of CryoPort Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -19.06% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.16, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CYRX is recording 449.93K average volume. On a monthly basis, the volatility of the stock is set at 4.96%, whereas on a weekly basis, it is put at 7.00%, with a gain of 1.30% over the past seven days. Furthermore, long-term investors anticipate a median target price of $18.00, showing growth from the present price of $16.40, which can serve as yet another indication of whether CYRX is worth investing in or should be passed over.
How Do You Analyze CryoPort Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.31%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 103.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CYRX shares are owned by institutional investors to the tune of 103.50% at present.
